Sleep apnea-hypopnea syndromes and heart failure;Síndromes de apneas-hipopneas durante el sueño e insuficiencia cardiaca

Revista Espanola de Cardiologia

Volumn 60, Issue 4, 2007, Pages 415-427

  Arias, Miguel A ^a   García Río, Francisco ^b   Alonso Fernández, Alberto ^c   Sánchez, Ana M ^a  

^a Servicio de Cardiologia   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Heart failure; Sleep apnea hypopnea syndrome; Treatment with continuous positive airway pressure

Indexed keywords

ACETAZOLAMIDE; ADENOSINE RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; OXYGEN; THEOPHYLLINE;

DISEASE ASSOCIATION; DISEASE COURSE; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PRELOAD; HUMAN; HYPOXIA; INFLAMMATION; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; REVIEW; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

EID: 34249992251     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101645     Document Type: Review

References (71)

1. Jiménez Navarro MF, Díez MJ, Delgado Jiménez JF, Crespo Leiro MG. La insuficiencia cardiaca en el año 2005. Rev Esp Cardiol. 2006;59:55-65.
2. Rodríguez-Artalejo F, Banegas B Jr, Guallar-Castillón P. Epidemiología de la instificiencia cardíaca. Rev Esp Cardiol. 2004;57:163-70.
3. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep. 1995;18:149-57.
4. Marín JM, Carrizo SJ, Vicente E, Agustí AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-53.
5. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Molisenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-41.
6. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-5.
7. Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation. 2005;112:375-83.
8. Arias MA, García-Río F, Alonso-Fernández A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106-13.
9. Arias MA, Alonso-Fernández A, García-Río F, Sánchez A, López JM, Pagola C. Obstructive sleep apnea in atrial fibrillation patients. Int J Cardiol. 2006;110:426.
10. García-Río F, Racionero MA, Pino JM, Martínez I, Ortuño F, Villasante C, et al. Sleep apnea and hypertension. Chest. 2000; 117:1417-25.
11. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-41.
12. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004;169:361-6.
13. Marti Al, Félez FM, Balcells E, Cladellas M, Broquetas J, Bruguera J. Prevalencia del síndrome de apnea obstructiva del sueño en pacientes con disfunción sinusal. Rev Esp Cardiol. 2006;59:28-32.
14. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84.
15. Terán SJ, Alonso Álvarez ML. Síndrome de apneas-hipopneas durante el sueño y corazón, Rev Esp Cardiol. 2006;59:5-8.
16. García-Río F. El síndrome de apneas del sueho como causa y consecuencia de insuficiencia cardiaca congestiva. Med Clin (Barc). 2001;116:312-4.
17. Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest. 2003;124:594-601.
18. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569-82.
19. Virolainen J, Ventila M, Turto H, Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol. 1995;79:455-60.
20. Brinker JA, Weiss JL, Lappe DL, Rabson JL, Summer WR, Permutt S, et al. Leftward septal displacement during right ventricular loading in man. Circulation. 1980;61:626-33.
21. Parker JD, Brooks D, Kozar LF, Render-Teixeira CL, Horner RL, Douglas BT, et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med. 1999;160:1888-96.
22. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162:2166-71.
23. Imadojernu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger UA. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2002;165:950-3.
24. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462-4.
25. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328:303-7.
26. Horner RL, Brooks D, Kezar LF, Tse S, Phillipson EA. Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol. 1995;79:151-62.
27. Eichhom EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 1996;94:2285-96.
28. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981-8.
29. Arzt M, Young T, Finn L, Skatrud JB, Ryan CM, Newton GE, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med. 2006;166:1716-22.
30. Daly PA, Sole MJ. Myocardial catecholamines and the pathophysiology of heart failure. Circulation. 1990;82:135-43.
31. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993;22:A72-84.
32. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570-8.
33. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990; 81:528-36.
34. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens. 1997;15:1227-33.
35. Fletcher EC, Proctor M, Yu J, Zhang J, Guardiola JJ, Hornung C, et al. Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med. 1999;160:1688-96.
36. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998;98:2269-75.
37. Sin DD, Fitzgerald F, Parker JD, Newton GE, Logan AG, Floras JS, et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest. 2003;123:1536-43.
38. Bradley TD, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest. 2001;119:1827-35.
39. Chaudhary BA, Ferguson DS, Speir WA Jr. Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest. 1982;82: 122-4.
40. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990;8:941-6.
41. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest. 1995; 107:1538-44.
42. Alchanatis M, Tourkohoriti G, Kosmas EN, Panoutsopoulos G, Kakouros S, Papadima K, et al. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J. 2002;20:1239-45.
43. Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet. 1991;338:1480-4.
44. Shivalkar B, Van de HC, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006;47:1433-9.
45. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoen-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest. 2002;122:1133-8.
46. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19-25.
47. Tremel F, Pepin JL, Veale D, Wuyam B, Siche JP, Mallion JM, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J. 1999;20:1201-9.
48. Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation. 1999;99:1574-9.
49. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160:1101-6.
50. Lofaso F, Verschueren P, Rande JL, Harf A, Goldenberg F. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest. 1994;106:1689-94.
51. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99:1435-40.
52. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154-9.
53. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829-36.
54. Chan J, Sanderson J, Chan W, Lai C, Choy D, Ho A, et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest. 1997;111:1488-93.
55. Barbé F, Mayoralas LR, Durán J, Masa JF, Maimo, A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001;134: 1015-23.
56. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-904.
57. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999;100:2332-5.
58. Alchanatis M, Paradellis G, Pini H, Tourkohoriti G, Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration. 2000;67:367-71.
59. Alonso-Fernández A, García-Río F, Arias MA, Mediano O, Pino JM, Martínez I, et al. Obstructive sleep apnoea-hypoapnoea syndrome reversibly depresses cardiac response to exercise. Eur Heart J. 2006;27:207-15.
60. 2 and Circulatory Delay. Circulation. 2001; 103:238-43.
61. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61-6.
62. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025-33.
63. Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation. 2003;107:727-32.
64. Garrigue S, Bordier P, Jais P, Shah DC, Hocim M, Raherison C, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med. 2002;346:404-12.
65. Luthje L, Unterberg-Buchwald C, Dajani D, Vollmann D, Hasenfuss G, Andreas S. Atrial overdrive pacing in patients with sleep apnea with implanted pacemaker. Am J Respir Crit Care Med. 2005;172:118-22.
66. Pepin JL, Defaye P, Garrigue S, Poezevara Y, Levy P. Overdrive atrial pacing does not improve obstructive sleep apnoea syndrome. Eur Respir J. 2005;25:343-7.
67. Franklin KA, Eriksson P, Sahlin C, Lundgren R. Reversal of central sleep apnea with oxygen. Chest. 1997;111:163-9.
68. Hardy PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med. 1989;111:777-82.
69. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation. 2000;101:392-7.
70. Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med. 1995;151:92-7.
71. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473-9.